LILLY (ELI) & COMPANY - Lilly Response to NY Times Article.

PR Newswire UK Disclose, March, 2008

 
Date: March 14, 2008 
 
For Release: Immediately 
 
Refer to: Tarra Ryker -- (317) 332-7502 mobile 
 
Marni Lemons -- (317) 532-7826 mobile 
 
Angela Sekston -- (317) 332-1593 mobile 
 
Statement from Eli Lilly and Company: Response to Today's New York Times 
Article, "Lilly E-Mail Discussed Off-Label Drug Use" 
 
INDIANAPOLIS, IN -- Eli Lilly and Company (NYSE: LLY) today called the 
assertions in a New York Times online article `flat out wrong.' The Times 
report in question focused on the State of Alaska v. Eli Lilly and Company 
trial that is underway and attempted to interpret a 2003 email from John C. 
Lechleiter, Ph.D., currently Lilly's president and chief operating officer. 
About this email and the Times report, the company makes the following 
statement: 
 
  * The...

            
        
    
    	    
                
                
	

		

					 
            Read the rest of this article with a Free Trial at HighBeam Research.
        				
 

    		            
	
                Premium Content Partnership | 
                	HighBeam Research provides an in-depth online archive library of reference works.